A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 9, 2016
- Accepted in final form October 21, 2016
- First Published December 15, 2016.
Author Disclosures
- Kaminie Moodley, FCN,
- Pierre L.A. Bill, FCN and
- Vinod Bhagu Patel, PhD
- Kaminie Moodley, FCN,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pierre L.A. Bill, FCN and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Vinod Bhagu Patel, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence to Dr. Patel: patelv{at}ukzn.ac.za or K. Moodley: Kaminie{at}live.co.za
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathyPariwat Thaisetthawatkul, Eric L. Logigian, David N. Herrmann et al.Neurology, November 26, 2002 -
Articles
PML-IRIS in patients with HIV infectionClinical manifestations and treatment with steroidsK. Tan, R. Roda, L. Ostrow et al.Neurology, January 07, 2009 -
Views & Reviews
Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathyB. Tackenberg, J. D. Lünemann, A. Steinbrecher et al.Neurology, May 07, 2007 -
Article
Chronic inflammatory demyelinating polyneuropathyClinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathyKenneth C. Gorson, Gregory Allam, Allan H. Ropper et al.Neurology, February 01, 1997